Biological Research For Nursing

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information on The Virtual Advisor

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lwaleed, B. A.
Right arrow Articles by Getliffe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lwaleed, B. A.
Right arrow Articles by Getliffe, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Biological Research For Nursing, Vol. 9, No. 2, 97-107 (2007)
DOI: 10.1177/1099800407305733

Tissue Factor: A Critical Role in Inflammation and Cancer

Bashir A. Lwaleed, PhD

Continence Technology and Skin Health Group, School of Nursing and Midwifery, University of Southampton, Southampton, United Kingdom, Department of Urology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom, bashir{at}soton.ac.uk

Alan J. Cooper, PhD

Department of Urology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom

David Voegeli, PhD, RN

Continence Technology and Skin Health Group, School of Nursing and Midwifery, University of Southampton, Southampton, United Kingdom

Kathryn Getliffe, PhD, RN

Continence Technology and Skin Health Group, School of Nursing and Midwifery, University of Southampton, Southampton, United Kingdom

A series of coordinated enzymatic reactions takes place in the body whenever blood clots. The major physiological initiator of these reactions is a membrane-bound glycoprotein known as tissue factor (TF), which is normally separated from the bloodstream by the vascular endothelium. Bleeding, caused by injury or tissue damage, activates a complex enzyme cascade as TF becomes exposed to the bloodstream. In disease states, leukocytes or the vascular endothelium may abnormally express TF to cause intravascular coagulation. The blood-coagulation cascade is also relevant to diseases such as hemophilia, in which patients are deficient in blood proteins necessary for clotting, and is linked to vascular diseases such as heart attack and stroke, in which clotting can lead to the occlusion of blood vessels. Coagulation is also activated in inflammation and cancer. In this article, we discuss characteristics of TF and review its role in inflammation and cancer.

Key Words: tissue factor • blood coagulation • inflammation • cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
D. Nguyen, S.-J. Lee, E. Libby, and C. Verschraegen
Rate of Thromboembolic Events in Mesothelioma
Ann. Thorac. Surg., March 1, 2008; 85(3): 1032 - 1038.
[Abstract] [Full Text] [PDF]